Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Research & Discovery » Proteomics & Protein Research » Inside Proteomics: ABI s Dave Hicks Sets out Strategy for Capitalizing on Proteomics

Inside Proteomics: ABI s Dave Hicks Sets out Strategy for Capitalizing on Proteomics

Jan 14, 2002
Premium

AT A GLANCE

Name: Dave Hicks

Position: Director of marketing for proteomics applications at Applied Biosystems’ Proteomics Research Center in Framingham, Mass.

Prior Experience: Served as Director of the protein business unit for ABI, and as senior marketing director and product line manager for PerSeptive Biosystems in Framingham, Mass., before its acquisition by ABI.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Herbert Tabor Dies

The Washington Post reports that Herbert Tabor, who worked at the US National Institutes of Health for 77 years, has died at 101.

Funds to Get Vaccines

The World Bank is seeking approval for a $12 billion plan to provide low-income nations with funds to procure SARS-CoV-2 vaccines, according to Reuters.

A Number on It

Science writes that public health officials and others are debating whether cycle threshold values should be included on SARS-CoV-2 results.

Nucleic Acids Research Studies on 3D SARS-CoV-2 Structures, Human Brain Atlas, More

In Nucleic Acids Research this week: online database of SARS-CoV-2 protein structures, atlas of the human brain, and more.

Oct
14
Featured Webinar

Application of ctDNA Analysis to Detect MRD and Predict Recurrence in Colorectal Cancer

Sponsored by
Inivata

Circulating tumor DNA (ctDNA) can allow clinicians and researchers to better understand which patients are at high risk of recurrence and should be offered intensified chemotherapy or selected for clinical trials.

Oct
29
Featured Webinar

How to Train Your DRAGEN for Pathology Informatics

Sponsored by
Illumina

Illumina’s BaseSpace Sequence Hub (BSSH) supports primary and secondary analysis of massively parallel sequencing data and can be applied to gene panel data that is generated as part of a clinical cancer assay performed in a pathology lab.

What's Popular?

In Proteomics & Protein Research

  1. Bruker Acquires Software Platform From Integrated Proteomics Applications

  2. Alzheimer's Disease Linked to Epigenetic Changes in Multi-Omic Study

  3. Genosity, Olink Proteomics Ink Strategic Collaboration

  4. Ionpath Expanding Sales Force, Investing in Informatics Tools Development

    Premium

  5. Ionpath Closes $18M Series B Round

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.